Catalyst by Wellstar designed to drive disruptive innovation Catalyst by Wellstar is the first-of-its-kind global digital health and innovation center created and operated within a health system to holistically address healthcare disruption by harnessing problems, solutions, investments, and partnerships across industries
Im proud to partner with Hybio Pharmaceutical Co., Ltd., a leading manufacturer in this field, dedicated to developing effective solutions for managing weight and blood sugar levels, Our GLP-1 Semaglutide is crafted to support your business growth and enhance patient outcomes
From there, it works throughout your body to reduce your appetite, slow digestion, and help regulate blood sugar levels
Absolute contraindications: Personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN2), known hypersensitivity to semaglutide or any excipient Relative contraindications: History of pancreatitis, severe gastrointestinal disease (gastroparesis, inflammatory bowel disease), current pregnancy or planned pregnancy within 2 months, history of suicidal ideation or major depressive disorder (monitor closely) Use with caution: Patients on insulin or sulfonylureas (hypoglycemia risk), patients with diabetic retinopathy (risk of transient worsening), patients with renal impairment (adjust monitoring) Pre-Treatment Workup Thorough semaglutide training for physicians includes a standardized pre-treatment assessment protocol
Semaglutide operates by delaying stomach emptying, thus reducing hunger and food intake effectively
It is produced naturally in the body and is found in every cell, playing a crucial role in protecting cells from oxidative stress and supporting detoxification processes
